News: POZEN Inc (POZN.OQ)
POZN.OQ on NASDAQ Stock Exchange Global Select Market
5.75USD
12:48pm EDT
5.75USD
12:48pm EDT
Price Change (% chg)
$-0.05 (-0.86%)
$-0.05 (-0.86%)
Prev Close
$5.80
$5.80
Open
$5.80
$5.80
Day's High
$5.87
$5.87
Day's Low
$5.75
$5.75
Volume
8,573
8,573
Avg. Vol
47,488
47,488
52-wk High
$6.94
$6.94
52-wk Low
$4.28
$4.28
Select another date:
Select another date:
- 5 Stocks Insiders Love Right Now
- FDA Decisions: Interesting Biotechnology Catalyst Events
- POZEN's CEO Discusses Q1 2013 Results - Earnings Call Transcript
- Pounding The Table On Pozen: Why There's Upside In This Misunderstood Name
- POZEN's CEO Hosts Analyst and Investor Update Conference (Transcript)
- 5 Stocks Under $10 Set to Soar
Press Releases
- POZEN to Present at the 24th Annual Piper Jaffray Healthcare Conference
- POZEN Announces Positive Results for the PA8140-102 Bioavailability Study
- POZEN Reports Third Quarter 2012 Financial Results and Positive PA32540 Clinical Updates
- POZEN Presents Positive PA32540 Pivotal Phase 3 Data at the American Heart Association Scientific Sessions 2012
- POZEN Announces November 8th Webcast of Third Quarter 2012 Results and November 6th Presentation of Phase 3 Results for PA32540 at AHA`s Scientific Sessions 2012
- POZEN Patents Upheld in Treximet Patent Litigation Appeal
- POZEN Announces PA32540 Provides Superior Antiplatlet Effects over a Standard of Care Regimen in a Phase 1 Study ("Co-Rx")
- POZEN to Present at the 2012 Stifel Nicolaus Healthcare Conference
- POZEN Provides Update on Its PA Program and Results of Its Type A Meeting with the FDA
- POZEN Reports PA32540 / PA8140 Updates and Second Quarter 2012 Financial Results

